BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21801134)

  • 1. Managing acute promyelocytic leukemia without conventional chemotherapy: is it possible?
    Park JH; Tallman MS
    Expert Rev Hematol; 2011 Aug; 4(4):427-36. PubMed ID: 21801134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy.
    Park JH; Tallman MS
    Oncology (Williston Park); 2011 Jul; 25(8):733-41. PubMed ID: 21874835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional induction and post-remission therapy in APL: have we arrived?
    Sanz MA; Iacoboni G; Montesinos P
    Best Pract Res Clin Haematol; 2014 Mar; 27(1):33-8. PubMed ID: 24907015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute promyelocytic leukemia: current strategies for the treatment of newly diagnosed disease.
    Sirulnik LA; Stone RM
    Clin Adv Hematol Oncol; 2005 May; 3(5):391-7, 429. PubMed ID: 16167012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy.
    Montesinos P; González JD; González J; Rayón C; de Lisa E; Amigo ML; Ossenkoppele GJ; Peñarrubia MJ; Pérez-Encinas M; Bergua J; Debén G; Sayas MJ; de la Serna J; Ribera JM; Bueno J; Milone G; Rivas C; Brunet S; Löwenberg B; Sanz M
    J Clin Oncol; 2010 Aug; 28(24):3872-9. PubMed ID: 20625122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
    Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
    J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials).
    Kelaidi C; Ades L; Chevret S; Sanz M; Guerci A; Thomas X; de Botton S; Raffoux E; Rayon C; Fegueux N; Bordessoule D; Rigal-Huguet F; Link H; Stoppa A; Vekhoff A; Meyer-Monard S; Castaigne S; Dombret H; Degos L; Fenaux P
    Leukemia; 2006 May; 20(5):905-7. PubMed ID: 16541143
    [No Abstract]   [Full Text] [Related]  

  • 9. Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses.
    Creutzig U; Zimmermann M; Dworzak M; Urban C; Henze G; Kremens B; Lakomek M; Bourquin JP; Stary J; Reinhardt D
    Br J Haematol; 2010 May; 149(3):399-409. PubMed ID: 20230404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
    Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
    Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study.
    Imaizumi M; Tawa A; Hanada R; Tsuchida M; Tabuchi K; Kigasawa H; Kobayashi R; Morimoto A; Nakayama H; Hamamoto K; Kudo K; Yabe H; Horibe K; Tsuchiya S; Tsukimoto I
    Br J Haematol; 2011 Jan; 152(1):89-98. PubMed ID: 20735397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide- and idarubicin-induced remissions in relapsed acute promyelocytic leukaemia: clinicopathological and molecular features of a pilot study.
    Kwong YL; Au WY; Chim CS; Pang A; Suen C; Liang R
    Am J Hematol; 2001 Apr; 66(4):274-9. PubMed ID: 11279639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expanding role of arsenic in acute promyelocytic leukemia.
    Tallman MS
    Semin Hematol; 2008 Jul; 45(3 Suppl 2):S25-9. PubMed ID: 18760708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia.
    Masetti R; Vendemini F; Zama D; Biagi C; Gasperini P; Pession A
    Expert Rev Anticancer Ther; 2012 Sep; 12(9):1191-204. PubMed ID: 23098119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute promyelocytic leukaemia.
    Fenaux P; Chomienne C; Degos L
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the role of arsenic in newly diagnosed APL?
    Tallman MS
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):659-66. PubMed ID: 19041605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for the treatment of acute promyelocytic leukaemia.
    Mandelli F
    J Intern Med Suppl; 1997; 740():23-7. PubMed ID: 9350178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.